Apr 12, 2017
EMERGO SUMMARY OF KEY POINTS:
Canada’s medical device market regulator Health Canada has enacted increased fees for Medical Device License (MDL) application reviews effective April 1, 2017.
The regulator published its new fee schedule (section 4 of the document) for Class II, III and IV new and amended MDL applications; Health Canada increases its review fees by two percent every year.
(All prices in Canadian dollars)
EMERGO SUMMARY OF KEY POINTS:
Canadian medical device market regulator Health Canada plans to reclassify products used to disinfect and sterilize medical devices from pharmaceuticals to devices.
Health Canada’s intake of Medical Device License (MDL) applications has shown a slow but steady decrease in the regulator’s number of license approvals from 2011 to mid-2016.